We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+27.36%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
AUM
$3.53B
AUM Growth
-$782M
Cap. Flow
-$472M
Cap. Flow %
-13.35%
Top 10 Hldgs %
78.19%
Holding
127
New
47
Increased
13
Reduced
16
Closed
35

Sector Composition

Rank Sector Weight
1 Miscellaneous 75.74%
2 Technology 6.52%
3 Financials 5.88%
4 Healthcare 5.08%
5 Communication Services 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$2.24B 63.49%
6,000,000
-2,500,000
-29% -$887M
EV
2
DELISTED
Eaton Vance Corp.
EV
$90M 2.55%
+1,325,284
New +$82.8M
VAR
3
DELISTED
Varian Medical Systems, Inc.
VAR
$89.3M 2.53%
510,069
+58,197
+13% +$10.1M
WTW icon
4
Willis Towers Watson
WTW
$31.9B
$63.5M 1.8%
301,361
+26,589
+10% +$5.47M
WORK
5
DELISTED
Slack Technologies, Inc.
WORK
$49.7M 1.41%
+1,175,826
New +$39.7M
MXIM
6
DELISTED
Maxim Integrated Products
MXIM
$49.2M 1.39%
554,446
-73,377
-12% -$5.79M
TIF
7
DELISTED
Tiffany & Co.
TIF
$46.5M 1.31%
353,372
-282,509
-44% -$36.2M
XLNX
8
DELISTED
Xilinx Inc
XLNX
$45.4M 1.29%
+320,562
New +$41.7M
IPHI
9
DELISTED
INPHI CORPORATION
IPHI
$45M 1.27%
+280,641
New +$39.4M
NGHC
10
DELISTED
National General Holdings Corp
NGHC
$41M 1.16%
1,200,240
-68,194
-5% -$2.32M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$40.6M 1.15%
+260,000
New +$33.4M
INFO
12
DELISTED
IHS Markit Ltd. Common Shares
INFO
$40.6M 1.15%
+451,425
New +$39.1M
EIDX
13
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$31.5M 0.89%
+239,762
New +$21.2M
CCL icon
14
PUT
Carnival Corporation Ltd
CCL
$33.9B
$29.4M 0.83%
1,357,400
+109,600
+9% +$1.95M
DISCK
15
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$25.4M 0.72%
969,977
+107,989
+13% +$2.37M
CBB
16
DELISTED
Cincinnati Bell Inc.
CBB
$25.3M 0.72%
1,654,458
-216,999
-12% -$3.3M
Z icon
17
Zillow
Z
$8.02B
$24.2M 0.69%
+186,803
New +$20.7M
RP
18
DELISTED
RealPage, Inc.
RP
$24.2M 0.68%
+277,199
New +$18.2M
CNK icon
19
PUT
Cinemark Holdings
CNK
$4.17B
$23.6M 0.67%
1,355,000
+455,000
+51% +$5.72M
NCLH icon
20
PUT
Norwegian Cruise Line
NCLH
$7.65B
$20.6M 0.58%
810,000
+300,000
+59% +$6.26M
GES
21
PUT
DELISTED
Guess Inc
GES
$19.3M 0.55%
851,800
+176,800
+26% +$2.79M
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
$15.9M 0.45%
+220,000
New +$11.5M
NIO icon
23
PUT
NIO
NIO
$10.9B
$14.3M 0.4%
292,500
BIIB icon
24
CALL
Biogen
BIIB
$32.3B
$12.8M 0.36%
+52,200
New +$13.5M
TDS icon
25
Telephone and Data Systems
TDS
$3.87B
$11.5M 0.32%
617,088
-6,106
-1% -$112K

Similar funds

DLD Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, DLD Asset Management held 127 positions worth $3.53B, down 18% from $4.32B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

DLD Asset Management withdrew a net $472M in Q4 2020, closing 35 positions and reducing 16 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $96.6M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.

Against the trend, DLD Asset Management opened a new position in Eaton Vance Corp. worth $90M.

  • DLD Asset Management's largest Q4 2020 buy was Eaton Vance Corp.: 1,325,284 shares worth $90M.
  • DLD Asset Management added most to Varian Medical Systems, Inc. in Q4 2020, an estimated $10.1M increase.
  • DLD Asset Management's biggest Q4 2020 reduction was Tiffany & Co., cutting an estimated $36.2M.
  • DLD Asset Management fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $96.6M.
  • DLD Asset Management's ten largest holdings make up 78% of its $3.53B portfolio in Q4 2020.
  • DLD Asset Management opened 47 new positions and closed 35 in Q4 2020.
  • DLD Asset Management's portfolio value fell 18% quarter-over-quarter to $3.53B.

Based on DLD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.